Proud of our STOP CP team’s new pub in @JAMACardio part of @JAMANetwork! ESC 0/1-Hour Algorithm With High-Sensitivity Cardiac Troponin T Among Patients With Coronary Artery Disease https://t.co/YyosEvh1eJ
Congratulations @johannesneuman @RTwerenbold on the late-breaking science ARTEMIS study presentation at #ESCCongress evaluating personalized diagnostic algorithms using machine learning for patients with suspected acute MI in a large international cohort involving 6 cTn assays.
Now in the latest @CircAHA issue, our primer endorsed by the IFCC C-CB addressing "High-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain" https://t.co/PBekkgL5ay @CcbIfcc
Common comorbid conditions broadly influence the diagnostic performance of troponin, important real-world clinical implications 👉 Check out our #ESCAbstract on the #ESCCongress https://t.co/3VfKRwlEK1 via @escardio@MahlerHEARTpath@bra07md
We are honored to announce today the formation of our Scientific Advisory Board.
The group is comprised of world-class experts, researchers and thought leaders spanning cardiology, emergency medicine and radiology.
Read our full press release here: https://t.co/F38ANVVjGH
Impact of hs #troponin T implementation: results of our @MayoClinicHS study addressing transition from 4th to 5th Gen cTnT are now available in latest @JACCJournals issue https://t.co/ywmiGp2Pse @iam_olatunde • Podcast https://t.co/9G5cbNSr2H • Editorial https://t.co/WRK27VH1nn
Congrats to third year resident @Nick_Ashburn1 for his award winning research presentation at the James E. Byrum Academic Forum titled “Prehospital time for patients with acute chest pain; a rural health disparity”
@reubixxcube@brian_hiestand We have been very successful integrating residents into our investigations of the HEART Pathway, prehospital risk stratification, biomarkers, cardiac imaging, etc...and we have fun doing it! DM me if you would like to find a time to chat.